Parabilis Medicines Inc
NASDAQ:PBLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Parabilis Medicines Inc
NASDAQ:PBLS
|
US |
|
C
|
Cara Therapeutics Inc
F:69C
|
US |
|
Fuse Cobalt Inc
XTSX:FUSE
|
CA |
|
M
|
Manhattan Corp Ltd
ASX:MHC
|
AU |
|
Leef Brands Inc
F:H3G
|
CA |
|
Rossiyskiy Aktsionernyi Kommercheskiy Dorozhnyi Bank PAO
MOEX:RDRB
|
RU |
Wall St Price Targets
PBLS Price Targets Summary
Parabilis Medicines Inc
According to Wall Street analysts, the average 1-year price target for PBLS is 42.59 USD with a low forecast of 40.4 USD and a high forecast of 47.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBLS's stock price target?
Price Target
42.59
USD
According to Wall Street analysts, the average 1-year price target for PBLS is 42.59 USD with a low forecast of 40.4 USD and a high forecast of 47.25 USD.